We have some already, so not to say that we're starting this without some knowledge. If you look at SickKids, for instance, they have a very good centre of excellence around pediatric cardiovascular diseases and rare diseases. There is a vasculitis centre there. In fact, the research projects that have just been funded by CIHR for emerging teams on rare diseases all actually constitute a centre of excellence. These centres have to be bigger than a single disease, obviously, so there are natural groupings of diseases that need to take place. They can be defined, certainly, by the cause of the disease; they can be defined by the whole host of organs that they actually impact, though many of these are multi-system diseases. So we actually have some of those in place.
What we would love to see is, in fact, a national consultation around that, bringing together the clinicians, the researchers, and the patient community. There's a whole format that the European Union has put together to host consultations around that discussion. Quite frankly, we want to get the orphan regulatory framework first, but we really would like to introduce that format into Canada so we aren't reinventing the wheel even in terms of how to do it.